{ "cik": 1498382, "cik_padded": "0001498382", "entityName": "TuHURA Biosciences, Inc./NV", "fiscal_years": [ { "accn": "0001193125-26-134950", "filed": "2026-03-31", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 76083.0, "cash": 3619949.0, "eps_diluted": -0.63, "free_cash_flow": -27705233.0, "net_income": -30051977.0, "operating_cash_flow": -27629150.0, "stockholders_equity": 20932328.0, "total_assets": 27353156.0, "total_liabilities": 6420828.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.306742183669203, "roa_avg2y": -1.2701639312389899, "roa_period_end": -1.098665799295701, "roe_avg2y": -1.6918155629136091, "roe_period_end": -1.4356729456943347 } }, { "accn": "0001193125-26-134950", "filed": "2026-03-31", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 57906.0, "cash": 12657178.0, "eps_diluted": -1.21, "free_cash_flow": -14786044.0, "net_income": -21682306.0, "operating_cash_flow": -14728138.0, "stockholders_equity": 14593976.0, "total_assets": 19966684.0, "total_liabilities": 5372708.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.36814559651187584, "roa_avg2y": -1.7824632246780778, "roa_period_end": -1.0859242325866427, "roe_avg2y": -3.3267239626765313, "roe_period_end": -1.4857024569589534 } }, { "accn": "0001193125-26-134950", "filed": "2026-03-31", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 79224.0, "cash": 3665032.0, "eps_diluted": -2.47, "free_cash_flow": -12030080.0, "net_income": -29316826.0, "operating_cash_flow": -11950856.0, "stockholders_equity": -1558746.0, "total_assets": 4361791.0, "total_liabilities": 5920537.0 }, "period_end": "2023-12-31", "ratio_units": { "roa_avg2y": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -2.886964814162785, "roe_avg2y": -5.456732241713622 } }, { "accn": "0000950170-25-047921", "filed": "2025-03-31", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 11780000.0, "net_income": -22661000.0, "operating_cash_flow": -20392000.0, "stockholders_equity": 12303941.0, "total_assets": 15948000.0, "total_liabilities": 4153000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.33753412829271534, "roa_avg2y": -1.5368078396799023, "roa_period_end": -1.4209305242036618, "roe_avg2y": -1.9804289641821669, "roe_period_end": -1.8417676092562538 } }, { "accn": "0000950170-23-048588", "filed": "2023-09-18", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 10537000.0, "net_income": -38298000.0, "operating_cash_flow": -18860000.0, "stockholders_equity": 10581000.0, "total_assets": 13543000.0, "total_liabilities": 2962000.0 }, "period_end": "2021-06-30", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.27993573386258386, "roa_avg2y": -4.647533523451247, "roe_avg2y": -7.063445223164884, "roe_period_end": -3.619506662886306 } }, { "accn": "0001564590-21-049235", "filed": "2022-09-27", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 2392000.0, "net_income": -9126000.0, "operating_cash_flow": -7928000.0, "stockholders_equity": 263000.0, "total_assets": 2938000.0, "total_liabilities": 2675000.0 }, "period_end": "2020-06-30", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roe_avg2y": "ratio" }, "ratios": { "leverage": 10.171102661596958, "roa_avg2y": -2.6166785300322353, "roe_avg2y": -8.181084715374272 } }, { "accn": "0001564590-21-049235", "filed": "2021-09-28", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 3718758.0, "net_income": -8048221.0, "operating_cash_flow": -6327425.0, "stockholders_equity": 1968000.0, "total_assets": 4037255.0, "total_liabilities": 2069725.0 }, "period_end": "2019-06-30", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.0516895325203253, "roa_avg2y": -1.44854955539497, "roa_period_end": -1.9934883974383586, "roe_avg2y": -2.174247891762817, "roe_period_end": -4.089543191056911 } }, { "accn": "0001564590-20-044019", "filed": "2020-09-18", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 5971995.0, "net_income": 11138312.0, "operating_cash_flow": -9850850.0, "stockholders_equity": 5435223.0, "total_assets": 7074855.0, "total_liabilities": 1639632.0 }, "period_end": "2018-06-30", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3016678432513257, "roa_avg2y": 1.4865079625642172, "roa_period_end": 1.574351983185521, "roe_avg2y": 1.8542611226955255, "roe_period_end": 2.0492833504715446 } }, { "accn": "0001213900-19-017497", "filed": "2019-09-09", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 6586014.0, "net_income": 8081764.0, "operating_cash_flow": -8019071.0, "stockholders_equity": 6578524.0, "total_assets": 7911021.0, "total_liabilities": 1332497.0 }, "period_end": "2017-06-30", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.20255257866354215, "roa_avg2y": 1.1329453935775458, "roa_period_end": 1.0215829284235245, "roe_avg2y": 1.4132290989605765, "roe_period_end": 1.2285071848943623 } }, { "accn": "0001213900-18-012876", "filed": "2018-09-24", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 6157264.0, "net_income": 8864864.0, "operating_cash_flow": -5145814.0, "stockholders_equity": 4858778.0, "total_assets": 6355799.0, "total_liabilities": 1497021.0 }, "period_end": "2016-06-30", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.30810648274113367, "roa_period_end": 1.3947678332810713, "roe_period_end": 1.8245048446337742 } }, { "accn": "0001013762-15-001103", "filed": "2015-11-16", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": 0.11 }, "period_end": "2015-06-30", "ratios": {} }, { "accn": "0001013762-15-001103", "filed": "2015-11-16", "fiscal_year": 2014, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": 0.0 }, "period_end": "2014-06-30", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-134950", "filed": "2026-03-31", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001498382.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001498382.json" }, "ticker": "HURA" }